Industry: Medical Devices & Consumables
Published Date: 2025-01-16
Pages: 79 Pages
Report ld: 3444726
Request Sample
Customized Report
Cell Saver Market Size(US$)

CAGR 2025-2031
3.5%
Market Size,2031
USD 340
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Cell Saver was valued at US$ 268 million in the year 2024 and is projected to reach a revised size of US$ 340 million by 2031, growing at a CAGR of 3.5% during the forecast period.
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. A blood salvage machine, also known as an autologous transfusion salvage system or an autologous blood transfusion machine, is a medical device used to salvage and process a patient"s own blood during surgery before returning it to the patient. Such a system could be used to reduce the need for exogenous blood transfusions during surgery, thereby reducing the risks and complications associated with blood transfusions for patients. The blood salvage machine works by collecting the blood produced in the patient"s body through a specialized system, processing it to remove impurities and platelet aggregation, and then returning the processed blood to the patient. This method is actually a form of autologous blood transfusion, because the blood returned comes from the patient itself, and there is no compatibility problem between the donor and the recipient.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Cell Saver, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Saver.
The Cell Saver market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Saver market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Saver manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Haemonetics
Medtronic
LivaNova
BD
Fresenius Kabi
Beijing ZKSK Technology
Segment by Type
Intraoperative Autotransfusion Systems
Postoperative Autotransfusion Systems
Dual-Mode Autotransfusion Systems
Segment by Application
Cardiac Surgeries
Orthopedic Surgeries
Organ Transplantation
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cell Saver manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cell Saver in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Cell Saver Market Overview
1.1 Product Definition
1.2 Cell Saver by Type
1.2.1 Global Cell Saver Market Value Comparison by Type (2024 VS 2031)
1.2.2 Intraoperative Autotransfusion Systems
1.2.3 Postoperative Autotransfusion Systems
1.2.4 Dual-Mode Autotransfusion Systems
1.3 Cell Saver by Application
1.3.1 Global Cell Saver Market Value by Application (2024 VS 2031)
1.3.2 Cardiac Surgeries
1.3.3 Orthopedic Surgeries
1.3.4 Organ Transplantation
1.3.5 Others
1.4 Global Cell Saver Market Size Estimates and Forecasts
1.4.1 Global Cell Saver Revenue 2020-2031
1.4.2 Global Cell Saver Sales 2020-2031
1.4.3 Global Cell Saver Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cell Saver Market Competition by Manufacturers
2.1 Global Cell Saver Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cell Saver Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cell Saver Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cell Saver, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cell Saver, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cell Saver, Product Type & Application
2.7 Global Key Manufacturers of Cell Saver, Date of Enter into This Industry
2.8 Global Cell Saver Market Competitive Situation and Trends
2.8.1 Global Cell Saver Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cell Saver Players Market Share by Revenue
2.8.3 Global Cell Saver Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cell Saver Market Scenario by Region
3.1 Global Cell Saver Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cell Saver Sales by Region: 2020-2031
3.2.1 Global Cell Saver Sales by Region: 2020-2025
3.2.2 Global Cell Saver Sales by Region: 2026-2031
3.3 Global Cell Saver Revenue by Region: 2020-2031
3.3.1 Global Cell Saver Revenue by Region: 2020-2025
3.3.2 Global Cell Saver Revenue by Region: 2026-2031
3.4 North America Cell Saver Market Facts & Figures by Country
3.4.1 North America Cell Saver Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cell Saver Sales by Country (2020-2031)
3.4.3 North America Cell Saver Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cell Saver Market Facts & Figures by Country
3.5.1 Europe Cell Saver Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cell Saver Sales by Country (2020-2031)
3.5.3 Europe Cell Saver Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cell Saver Market Facts & Figures by Region
3.6.1 Asia Pacific Cell Saver Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cell Saver Sales by Region (2020-2031)
3.6.3 Asia Pacific Cell Saver Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cell Saver Market Facts & Figures by Country
3.7.1 Latin America Cell Saver Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cell Saver Sales by Country (2020-2031)
3.7.3 Latin America Cell Saver Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cell Saver Market Facts & Figures by Country
3.8.1 Middle East and Africa Cell Saver Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cell Saver Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cell Saver Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cell Saver Sales by Type (2020-2031)
4.1.1 Global Cell Saver Sales by Type (2020-2025)
4.1.2 Global Cell Saver Sales by Type (2026-2031)
4.1.3 Global Cell Saver Sales Market Share by Type (2020-2031)
4.2 Global Cell Saver Revenue by Type (2020-2031)
4.2.1 Global Cell Saver Revenue by Type (2020-2025)
4.2.2 Global Cell Saver Revenue by Type (2026-2031)
4.2.3 Global Cell Saver Revenue Market Share by Type (2020-2031)
4.3 Global Cell Saver Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cell Saver Sales by Application (2020-2031)
5.1.1 Global Cell Saver Sales by Application (2020-2025)
5.1.2 Global Cell Saver Sales by Application (2026-2031)
5.1.3 Global Cell Saver Sales Market Share by Application (2020-2031)
5.2 Global Cell Saver Revenue by Application (2020-2031)
5.2.1 Global Cell Saver Revenue by Application (2020-2025)
5.2.2 Global Cell Saver Revenue by Application (2026-2031)
5.2.3 Global Cell Saver Revenue Market Share by Application (2020-2031)
5.3 Global Cell Saver Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Haemonetics
6.1.1 Haemonetics Company Information
6.1.2 Haemonetics Description and Business Overview
6.1.3 Haemonetics Cell Saver Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Haemonetics Cell Saver Product Portfolio
6.1.5 Haemonetics Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Cell Saver Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic Cell Saver Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 LivaNova
6.3.1 LivaNova Company Information
6.3.2 LivaNova Description and Business Overview
6.3.3 LivaNova Cell Saver Sales, Revenue and Gross Margin (2020-2025)
6.3.4 LivaNova Cell Saver Product Portfolio
6.3.5 LivaNova Recent Developments/Updates
6.4 BD
6.4.1 BD Company Information
6.4.2 BD Description and Business Overview
6.4.3 BD Cell Saver Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BD Cell Saver Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Fresenius Kabi
6.5.1 Fresenius Kabi Company Information
6.5.2 Fresenius Kabi Description and Business Overview
6.5.3 Fresenius Kabi Cell Saver Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Fresenius Kabi Cell Saver Product Portfolio
6.5.5 Fresenius Kabi Recent Developments/Updates
6.6 Beijing ZKSK Technology
6.6.1 Beijing ZKSK Technology Company Information
6.6.2 Beijing ZKSK Technology Description and Business Overview
6.6.3 Beijing ZKSK Technology Cell Saver Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Beijing ZKSK Technology Cell Saver Product Portfolio
6.6.5 Beijing ZKSK Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cell Saver Industry Chain Analysis
7.2 Cell Saver Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cell Saver Production Mode & Process Analysis
7.4 Cell Saver Sales and Marketing
7.4.1 Cell Saver Sales Channels
7.4.2 Cell Saver Distributors
7.5 Cell Saver Customer Analysis
8 Cell Saver Market Dynamics
8.1 Cell Saver Industry Trends
8.2 Cell Saver Market Drivers
8.3 Cell Saver Market Challenges
8.4 Cell Saver Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Cell Saver was estimated to be worth US$ 277 million in 2025 and is projected to reach US$ 351 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 133
USD 3950.00
(Single User License)
The global Cell Saver market was valued at US$ 277 million in 2025 and is anticipated to reach US$ 351 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 111
USD 2900.00
(Single User License)
The global Cell Saver market size was US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
The global Cell Saver market is projected to grow from US$ 268 million in 2024 to US$ 340 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 144
USD 4900.00
(Single User License)
The global market for Cell Saver was estimated to be worth US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 106
USD 3950.00
(Single User License)
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published Date: 2024-04-12
Pages: 95
USD 4900.00
(Single User License)
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published Date: 2024-01-17
Pages: 80
USD 2900.00
(Single User License)
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published Date: 2024-01-10
Pages: 100
USD 3950.00
(Single User License)
The global market for Cell Saver was estimated to be worth US$ 277 million in 2025 and is projected to reach US$ 351 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 133
The global Cell Saver market was valued at US$ 277 million in 2025 and is anticipated to reach US$ 351 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-04-17
Pages: 111
The global Cell Saver market size was US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
The global Cell Saver market is projected to grow from US$ 268 million in 2024 to US$ 340 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 144
The global market for Cell Saver was estimated to be worth US$ 268 million in 2024 and is forecast to a readjusted size of US$ 340 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 106
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published: 2024-04-12
Pages: 95
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published: 2024-01-17
Pages: 80
To recycle the blood, a machine known as a cell saver is used to collect what a patient loses during surgery, rinse away unneeded fat and tissue, and then centrifuge and separate the red cells, which are then returned to the patient should he or she need it.
Published: 2024-01-10
Pages: 100
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now